TY - JOUR
T1 - Additional organ resection combined with pancreaticoduodenectomy does not increase postoperative morbidity and mortality
AU - Nikfarjam, Mehrdad
AU - Sehmbey, Mandeep
AU - Kimchi, Eric T.
AU - Gusani, Niraj J.
AU - Shereef, Serene
AU - Avella, Diego M.
AU - Staveley-O'Carroll, Kevin F.
N1 - Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2009/5
Y1 - 2009/5
N2 - Background: The mortality associated with pancreaticoduodenectomy (PD) has decreased substantially in recent times, but high morbidity continues to be a significant problem. With reductions in mortality, there is increasing willingness to combine organ resections with PD when indicated. There is, however, a paucity of information regarding the morbidity and mortality of multivisceral resection (MVR) that involves pancreaticoduodenectomy (MVR-PD). Methods: Patients undergoing PD between January 2002 and November 2007 by a single surgeon were reviewed and perioperative outcomes determined. Those treated by PD alone were compared to those undergoing MVR-PD. Results: There were 105 patients overall who underwent PD during the study period, with MVR-PD performed in 19 patients. Twelve (63%) patients required PD combined with right colectomy, two (11%) underwent PD combined with right nephrectomy, two (11%) required liver resection with PD, and the remaining three (16%) had various combinations of kidney, colon, adrenal and small bowel resection in addition to PD. In both groups, the main indication for surgery was pancreatic cancer; however, there were proportionally more patients in the MVR-PD group with gastrointestinal stromal tumors (two (11%) patients), sarcomas (two (11%) patients) and metastases to the periampullary region (three (16%) patients). The overall complication rate in this study was 60%. Delayed gastric emptying (39%) and pancreatic fistula (16%) were the most common complications. There was no significant difference in complications between the two groups. A non pylorus-preserving PD was more commonly performed in cases of MVR-PD (53% vs 28%; p∈=∈0.007), operating times were longer (9.5 vs 8 h; p∈=∈0.002), and surgical intensive care unit stay was greater (2 vs 1 days; p∈<∈0.001). The overall median length of hospital stay (7 days) and readmission rate were similar between the groups. Conclusion: MVR-PD can be performed without significant added morbidity compared to PD alone. The main indication for MVR-PD is locally advanced pancreatic cancer requiring PD combined with right hemicolectomy.
AB - Background: The mortality associated with pancreaticoduodenectomy (PD) has decreased substantially in recent times, but high morbidity continues to be a significant problem. With reductions in mortality, there is increasing willingness to combine organ resections with PD when indicated. There is, however, a paucity of information regarding the morbidity and mortality of multivisceral resection (MVR) that involves pancreaticoduodenectomy (MVR-PD). Methods: Patients undergoing PD between January 2002 and November 2007 by a single surgeon were reviewed and perioperative outcomes determined. Those treated by PD alone were compared to those undergoing MVR-PD. Results: There were 105 patients overall who underwent PD during the study period, with MVR-PD performed in 19 patients. Twelve (63%) patients required PD combined with right colectomy, two (11%) underwent PD combined with right nephrectomy, two (11%) required liver resection with PD, and the remaining three (16%) had various combinations of kidney, colon, adrenal and small bowel resection in addition to PD. In both groups, the main indication for surgery was pancreatic cancer; however, there were proportionally more patients in the MVR-PD group with gastrointestinal stromal tumors (two (11%) patients), sarcomas (two (11%) patients) and metastases to the periampullary region (three (16%) patients). The overall complication rate in this study was 60%. Delayed gastric emptying (39%) and pancreatic fistula (16%) were the most common complications. There was no significant difference in complications between the two groups. A non pylorus-preserving PD was more commonly performed in cases of MVR-PD (53% vs 28%; p∈=∈0.007), operating times were longer (9.5 vs 8 h; p∈=∈0.002), and surgical intensive care unit stay was greater (2 vs 1 days; p∈<∈0.001). The overall median length of hospital stay (7 days) and readmission rate were similar between the groups. Conclusion: MVR-PD can be performed without significant added morbidity compared to PD alone. The main indication for MVR-PD is locally advanced pancreatic cancer requiring PD combined with right hemicolectomy.
UR - http://www.scopus.com/inward/record.url?scp=64749105989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=64749105989&partnerID=8YFLogxK
U2 - 10.1007/s11605-009-0801-2
DO - 10.1007/s11605-009-0801-2
M3 - Article
C2 - 19198960
AN - SCOPUS:64749105989
SN - 1091-255X
VL - 13
SP - 915
EP - 921
JO - Journal of Gastrointestinal Surgery
JF - Journal of Gastrointestinal Surgery
IS - 5
ER -